Skip to content
Open access

Late-onset versus adult-onset multiple sclerosis: A comparative analysis of clinical, radiological, and confirmed disability progression.

Sep 2026 · Multiple Sclerosis and Related Disorders · Vol 115, pp. 107923 · 0 citations · 27 references
Medicine

TL;DR

Patients with LOMS tend to have a higher prevalence of PPMS, a greater burden of comorbidities, higher baseline disability, lower relapse activity, and a shorter time to CDP.

Abstract

Background

Multiple sclerosis (MS) is a chronic, immune-mediated disorder of the central nervous system (CNS). In Egypt, its occurrence is approximately 13.7 per 100,000 inhabitants. The average age of onset for relapsing-remitting MS (RRMS) is between the second and fourth decades of life.

Objectives

To determine the differences in clinical characteristics, disease course, and progression between adult-onset MS (AOMS) and late-onset MS (LOMS). SUBJECTS AND

Methods

This observational comparative study was conducted on patients diagnosed with MS according to the revised McDonald criteria at the MS Clinic of Kasr Al-Ainy Hospital, Cairo University. Patients with AOMS (111) and LOMS (54) were compared based on various parameters, with longitudinal assessment of disease progression.

Results

The LOMS group had a significantly higher proportion of patients with primary progressive MS (PPMS) than the AOMS group. Additionally, the LOMS group had significantly fewer relapses, a lower annualized relapse rate (ARR), a longer disease duration and longer time to treatment, and a higher baseline EDSS score than the AOMS group (P < 0.05). Regarding baseline brain MRI findings, a higher percentage of LOMS patients had infratentorial lesions (P = 0.0002). LOMS patients also experienced earlier confirmed disability progression (CDP). The median time to CDP was 71 months (95% CI, 31.7-94.4) in the LOMS group and 113.6 months (95% CI, 81.2-142.0) in the AOMS group. In a stepwise Cox proportional hazards regression analysis, LOMS status remained significantly associated with CDP, (HR = 1.89, 95% CI 1.05-3.42, P = 0.035), indicating an approximately 89% higher risk of CDP compared with AOMS.

Conclusion

The present study adds data from an Egyptian cohort and highlights significant differences between AOMS and LOMS. Patients with LOMS tend to have a higher prevalence of PPMS, a greater burden of comorbidities, higher baseline disability, lower relapse activity, and a shorter time to CDP.

Read PDF

Similar papers

Review Open access Oct 2026

Association of Diagnosis Age with Clinical Characteristics and MRI Findings in Multiple Sclerosis

Background: Age at multiple sclerosis (MS) diagnosis may be associated with clinical course, inflammatory activity, and disability accrual, but evidence across the full age spectrum remains limited. We compared clinical and radiological features, phenotype distribution, and time to first post-diagnosis relapse across e...

O. Mirmosayyeb, Sepehr Aghajanian, Fatemeh Mohammadifard et al. · 0 citations
Open access Sep 2026

Pediatric-onset multiple sclerosis in Finland.

POMS is rare in Finland, and although ON was seen in 32% of all cases of CIS, other mono- and multifocal manifestations predominated in those who developed POMS.

Salla Hautala, Adrian Malén-Louekari, M. Westerholm-Ormio et al. · 0 citations
Open access Sep 2026

Clinical and laboratory differences between early- and late-onset systemic sclerosis: A comparative analytical study.

Objective: To compare the clinical and laboratory changes between early- and late-onset systemic sclerosis. Study Design: Comparative Analytical Cross-sectional study. Setting: Fauji Foundation Hospital (FFH), Rawalpindi (RWP). Period: 1st September, 2025 to February, 2026. Methods: A non-probability consecutive sampli...

Madiha Noor, Tehreem Sultana Hamid, Shahida Perveen et al. · 0 citations
Open access Aug 2026

Clinical and immunological markers of transformation of an acute demyelinating episode to a chronic demyelinating disease

An acute demyelinating episode (ADE) is the acute onset of clinical symptoms characteristic of multiple sclerosis (MS) or other demyelinating diseases (DD). Patients with ADE may experience either a monophasic course of the disease, relapses, or transformation to MS (up to 33 per cent). To date, there are no criteria f...

G. I. Sadekova, В. М. Гришина, M. Kozin et al. · 0 citations
Aug 2026

Age-stratified clinical characteristics and disability outcomes in neuromyelitis optica spectrum disorder: A cross-sectional study.

Age at diagnosis may represent a relevant clinical factor when evaluating disability burden in NMOSD and further prospective multicenter studies are warranted to better define longitudinal outcomes and prognostic factors in LO-NMOSD.

O. Mirmosayyeb, Mehra Fekri, Mohammad Yazdan Panah et al. · 0 citations
Open access Aug 2026

Multiple Sclerosis in Childhood: Report of 24 Cases from a Single-Center Experience

Aim: To examine the clinical, radiological, and therapeutic characteristics of pediatric patients with multiple sclerosis (MS) at a single tertiary center.Methods: This retrospective study included 24 patients diagnosed with MS according to the 2017 revised McDonald criteria. The demographic, clinical, neurophysiologic...

Şakir Genç, C. Tsakir, Furkan Donbaloğlu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.